Pancreatic Cancer Research

ResearcherRutgers, The State University of New JerseyNo recent work listed

H. Richard Alexander

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0687-9434; OpenAlex author ID A5081233015, A5112483093. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
36
Papers, trials and grants by year

2012: 1 paper · 2013: 3 papers · 2014: none · 2015: none · 2016: 3 papers · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper

Papers 13

  1. Association between SMAD4 Mutations and GATA6 Expression in Paired Pancreatic Ductal Adenocarcinoma Tumor Specimens: Data from Two Independent Molecularly-Char… Co-author DOI 10.3390/biomedicines11113058↗
  2. Bias and Pancreatic Cancer Reporting. First author DOI 10.1093/jnci/djac020↗
  3. Neoadjuvant Therapy for Pancreatic Cancer: Increased Use and Improved Optimal Outcomes. Co-author DOI 10.1097/xcs.0000000000000095↗
  4. Outcomes of patients with borderline resectable and resectable pancreatic adenocarcinoma treated with neoadjuvant three-week course chemoradiotherapy using cap… Co-author DOI 10.21037/jgo-21-503↗
  5. NO• /RUNX3/kynurenine metabolic signaling enhances disease aggressiveness in pancreatic cancer. Co-author DOI 10.1002/ijc.32733↗
  6. Subcategorizing T1 Staging in Pancreatic Adenocarcinoma Predicts Survival in Patients Undergoing Resection: An Analysis of the National Cancer Database. Co-author DOI 10.1089/pancan.2019.0017↗
  7. A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2. Co-author DOI 10.1158/0008-5472.can-15-2841↗
  8. Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-16-0511↗
  9. Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer. Co-author DOI 10.18632/oncotarget.10323↗
  10. Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pa… Co-author DOI 10.1002/ijc.27736↗
  11. FOXL1, a novel candidate tumor suppressor, inhibits tumor aggressiveness and predicts outcome in human pancreatic cancer. Co-author DOI 10.1158/0008-5472.can-13-0362↗
  12. Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-13-0209↗
  13. DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma. Co-author DOI 10.1371/journal.pone.0031507↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Howard S. Höchster · 2 shared papers, 2021–2022 · strength 0.44
  2. Nader N Hanna · 8 shared papers, 2012–2020 · strength 0.36
  3. Β. Michael Ghadimi · 8 shared papers, 2012–2020 · strength 0.36
  4. Jochen Gaedcke · 8 shared papers, 2012–2020 · strength 0.36
  5. S. Perwez Hussain · 8 shared papers, 2012–2020 · strength 0.36
  6. Shouhui Yang · 4 shared papers, 2016–2020 · strength 0.24
  7. Jian Wang · 4 shared papers, 2016–2020 · strength 0.24
  8. Matthias M. Gaida · 4 shared papers, 2016–2020 · strength 0.24
  9. Salma K. Jabbour · 2 shared papers, 2020–2021 · strength 0.21
  10. Dong Ho Lee · 3 shared papers, 2012–2020 · strength 0.17
  11. Mariam F. Eskander · 1 shared paper, 2023 · strength 0.17
  12. Subhajyoti De · 1 shared paper, 2023 · strength 0.17
  13. Colin M. Court · 1 shared paper, 2023 · strength 0.17
  14. Joshua D. Greendyk · 1 shared paper, 2023 · strength 0.17
  15. Brett Logan Ecker · 1 shared paper, 2023 · strength 0.17
  16. Catherine H. Davis · 1 shared paper, 2022 · strength 0.15
  17. Joal D. Beane · 1 shared paper, 2022 · strength 0.15
  18. Henry Anthony Pitt · 1 shared paper, 2022 · strength 0.15
  19. Geng Zhang · 4 shared papers, 2012–2013 · strength 0.12
  20. Shane S. Neibart · 1 shared paper, 2021 · strength 0.11
  21. Lyudmyla Derby Berim · 1 shared paper, 2021 · strength 0.11
  22. Prateek Gulhati · 1 shared paper, 2021 · strength 0.11
  23. Naotake Funamizu · 3 shared papers, 2012–2016 · strength 0.10
  24. Stephanie H. Greco · 1 shared paper, 2020 · strength 0.10
  25. Mihir M. Shah · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.